John T. Treace, Chief Executive Offer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 20,000 shares at $21.67 ($433K) on 2022-11-17, disclosed to the SEC on 2022-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.67 | 10,000 | $217K | 50.0% |
| 2 | $21.67 | 10,000 | $217K | 50.0% |
| Total | $21.67 avg | 20,000 | $433K | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |